{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T15:11:26Z","timestamp":1791558686142,"version":"4.3.4"},"reference-count":48,"publisher":"Wiley","issue":"S5","license":[{"start":{"date-parts":[[2021,9,21]],"date-time":"2021-09-21T00:00:00Z","timestamp":1632182400000},"content-version":"vor","delay-in-days":20,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP 1191665"],"award-info":[{"award-number":["OPP 1191665"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1190661"],"award-info":[{"award-number":["OPP1190661"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI136664"],"award-info":[{"award-number":["R01AI136664"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J Int AIDS Soc."],"published-print":{"date-parts":[[2021,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Introduction<\/jats:title><jats:p>Model\u2010based estimates of key HIV indicators depend on past epidemic trends that are derived based on assumptions about HIV disease progression and mortality in the absence of antiretroviral treatment (ART). Population\u2010based HIV Impact Assessment (PHIA) household surveys conducted between 2015 and 2018 found substantial numbers of respondents living with untreated HIV infection. CD4 cell counts measured in these individuals provide novel information to estimate HIV disease progression and mortality rates off ART.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We used Bayesian multi\u2010parameter evidence synthesis to combine data on (1) cross\u2010sectional CD4 cell counts among untreated adults living with HIV from 10 PHIA surveys, (2) survival after HIV seroconversion in East African seroconverter cohorts, (3) post\u2010seroconversion CD4 counts and (4) mortality rates by CD4 count predominantly from European, North American and Australian seroconverter cohorts. We used incremental mixture importance sampling to estimate HIV natural history and ART uptake parameters used in the Spectrum software. We validated modelled trends in CD4 count at ART initiation against ART initiator cohorts in sub\u2010Saharan Africa.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Median untreated HIV survival decreased with increasing age at seroconversion, from 12.5 years [95% credible interval (CrI): 12.1\u201312.7] at ages 15\u201324 to 7.2 years (95% CrI: 7.1\u20137.7) at ages 45\u201354. Older age was associated with lower initial CD4 counts, faster CD4 count decline and higher HIV\u2010related mortality rates. Our estimates suggested a weaker association between ART uptake and HIV\u2010related mortality rates than previously assumed in Spectrum. Modelled CD4 counts in untreated people living with HIV matched recent household survey data well, though some intercountry variation in frequencies of CD4 counts above 500 cells\/mm<jats:sup>3<\/jats:sup> was not explained. Trends in CD4 counts at ART initiation were comparable to data from ART initiator cohorts. An alternate model that stratified progression and mortality rates by sex did not improve model fit appreciably.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Synthesis of multiple data sources results in similar overall survival as previous Spectrum parameter assumptions but implies more rapid progression and longer survival in lower CD4 categories. New natural history parameter values improve consistency of model estimates with recent cross\u2010sectional CD4 data and trends in CD4 counts at ART initiation.<\/jats:p><\/jats:sec>","DOI":"10.1002\/jia2.25784","type":"journal-article","created":{"date-parts":[[2021,9,21]],"date-time":"2021-09-21T16:14:44Z","timestamp":1632240884000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Disease progression and mortality with untreated HIV infection: evidence synthesis of HIV seroconverter cohorts, antiretroviral treatment clinical cohorts and population\u2010based survey data"],"prefix":"10.1002","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4936-0264","authenticated-orcid":false,"given":"Robert","family":"Glaubius","sequence":"first","affiliation":[{"name":"Center for Modeling, Planning and Policy Analysis, Avenir Health  Glastonbury Connecticut USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikhil","family":"Kothegal","sequence":"additional","affiliation":[{"name":"Public Health Institute\/CDC Global Health Fellow Centers for Disease Control and Prevention  Atlanta Georgia USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sehin","family":"Birhanu","sequence":"additional","affiliation":[{"name":"Division of Global HIV\/AIDS Centers for Disease Control and Prevention  Atlanta Georgia USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sasi","family":"Jonnalagadda","sequence":"additional","affiliation":[{"name":"Division of Global HIV\/AIDS Centers for Disease Control and Prevention  Atlanta Georgia USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9460-4232","authenticated-orcid":false,"given":"Severin Guy","family":"Mahiane","sequence":"additional","affiliation":[{"name":"Center for Modeling, Planning and Policy Analysis, Avenir Health  Glastonbury Connecticut USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2717-011X","authenticated-orcid":false,"given":"Leigh F.","family":"Johnson","sequence":"additional","affiliation":[{"name":"Centre for Infectious Disease Epidemiology and Research University of Cape Town  Cape Town South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0617-3848","authenticated-orcid":false,"given":"Tim","family":"Brown","sequence":"additional","affiliation":[{"name":"Research Program, East\u2010West Center  Honolulu Hawaii USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7236-1989","authenticated-orcid":false,"given":"John","family":"Stover","sequence":"additional","affiliation":[{"name":"Center for Modeling, Planning and Policy Analysis, Avenir Health  Glastonbury Connecticut USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tara D.","family":"Mangal","sequence":"additional","affiliation":[{"name":"MRC Centre for Global Infectious Disease Analysis School of Public Health Imperial College London  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikos","family":"Pantazis","sequence":"additional","affiliation":[{"name":"National and Kapodistrian University of Athens Medical School  Athens Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7728-728X","authenticated-orcid":false,"given":"Jeffrey W.","family":"Eaton","sequence":"additional","affiliation":[{"name":"MRC Centre for Global Infectious Disease Analysis School of Public Health Imperial College London  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2021,9,21]]},"reference":[{"key":"e_1_2_11_2_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000002357"},{"key":"e_1_2_11_3_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000002437"},{"key":"e_1_2_11_4_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000002324"},{"key":"e_1_2_11_5_1","doi-asserted-by":"publisher","DOI":"10.1097\/EDE.0000000000000324"},{"key":"e_1_2_11_6_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002468"},{"issue":"2","key":"e_1_2_11_7_1","first-page":"ii28","article-title":"Derivation of parameters used in Spectrum for eligibility for antiretroviral therapy and survival on antiretroviral therapy","volume":"86","author":"Mahy M","year":"2010","journal-title":"Sex Transm Infect"},{"key":"e_1_2_11_8_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.aids.0000299411.75269.e8"},{"key":"e_1_2_11_9_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.aids.0000299412.82893.62"},{"key":"e_1_2_11_10_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000001437"},{"key":"e_1_2_11_11_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0032369"},{"key":"e_1_2_11_12_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir494"},{"key":"e_1_2_11_13_1","unstructured":"ICAP at Columbia University.PHIA Project: a drop that counts.https:\/\/phia.icap.columbia.edu\/. Accessed 3 March 2021."},{"key":"e_1_2_11_14_1","unstructured":"Ministry of Health (MoH) Cameroon.Cameroon Population\u2010Based HIV Impact Assessment (CAMPHIA) 2017: summary sheet.MoH:2018."},{"key":"e_1_2_11_15_1","unstructured":"Ministry of Health and Public Hygiene (MSHP) C\u00f4te d'Ivoire.C\u00f4te d'Ivoire Population\u2010Based HIV Impact Assessment (CIPHIA) 2017\u20132018: summary sheet. MSHP:2018."},{"key":"e_1_2_11_16_1","volume-title":"Swaziland HIV Incidence Measurement Survey 2 (SHIMS2) 2016\u20132017","author":"Government of the Kingdom of Eswatini","year":"2019"},{"key":"e_1_2_11_17_1","unstructured":"Ministry of Health Malawi.Malawi Population\u2010Based HIV Impact Assessment (MPHIA) 2015\u20132016: final report.Lilongwe:Ministry of Health;2018."},{"key":"e_1_2_11_18_1","unstructured":"Ministry of Health and Social Services (MoHSS) Namibia.Namibia Population\u2010Based HIV Impact Assessment (NAMPHIA) 2017: final report.Windhoek:MoHSS;2019."},{"key":"e_1_2_11_19_1","unstructured":"Federal Ministry of Health (FMoH) Nigeria.Nigeria HIV\/AIDS Indicator and Impact Survey (NAIIS) 2018: National Summary Sheet. FMoH:2019."},{"key":"e_1_2_11_20_1","unstructured":"Tanzania Commission for AIDS (TACAIDS);Zanzibar AIDS Commission (ZAC).Tanzania HIV Impact Survey (THIS) 2016\u201317: final report.Dar es Salaam Tanzania:2018."},{"key":"e_1_2_11_21_1","unstructured":"Ministry of Health (MoH) Uganda.Uganda Population\u2010Based HIV Impact Assessment (UPHIA) 2016\u20132017: final report.Kampala:MoH;2019."},{"key":"e_1_2_11_22_1","unstructured":"Ministry of Health and Child Care (MOHCC) Zimbabwe.Zimbabwe Population\u2010Based HIV Impact Assessment (ZIMPHIA) 2015\u20132016: final report.Harare:MOHCC;2019."},{"key":"e_1_2_11_23_1","unstructured":"Ministry of Health Zambia.Zambia Population\u2010Based HIV Impact Assessment (ZAMPHIA) 2016: final report.Lusaka:Ministry of Health;2019."},{"key":"e_1_2_11_24_1","doi-asserted-by":"publisher","DOI":"10.1258\/jhsrp.2008.008020"},{"key":"e_1_2_11_25_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40273-017-0494-4"},{"key":"e_1_2_11_26_1","doi-asserted-by":"publisher","DOI":"10.1177\/0272989X13493143"},{"key":"e_1_2_11_27_1","unstructured":"Eaton J Maheu\u2010GirouxM Gigu\u00e8reK&BhatkotiR.first90: the first90 model 2020 [Jun. 10 2021].https:\/\/github.com\/mrc\u2010ide\/first90release."},{"key":"e_1_2_11_28_1","doi-asserted-by":"publisher","DOI":"10.1136\/sextrans-2012-050640"},{"key":"e_1_2_11_29_1","doi-asserted-by":"publisher","DOI":"10.1086\/524686"},{"key":"e_1_2_11_30_1","unstructured":"United Nations Department of Economic and Social Affairs Population Division.World population prospects 2019: volume 1: comprehensive tables.2019."},{"key":"e_1_2_11_31_1","unstructured":"Joint United Nations Programme on HIV\/AIDS (UNAIDS).Fact sheet \u2014 global AIDS update 2019.Geneva:UNAIDS;2019."},{"key":"e_1_2_11_32_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix915"},{"key":"e_1_2_11_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)02061-4"},{"issue":"2","key":"e_1_2_11_34_1","first-page":"ii93","article-title":"A stochastic infection rate model for estimating and projecting national HIV prevalence rates","volume":"86","author":"Bao L","year":"2010","journal-title":"Sex Transm Infect"},{"key":"e_1_2_11_35_1","volume-title":"Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach","author":"World Health Organization","year":"2013"},{"key":"e_1_2_11_36_1","volume-title":"Guideline on when to start antiretroviral therapy and on pre\u2010exposure prophylaxis for HIV","author":"World Health Organization","year":"2015"},{"key":"e_1_2_11_37_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000000483"},{"key":"e_1_2_11_38_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000002358"},{"key":"e_1_2_11_39_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0005790"},{"key":"e_1_2_11_40_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy347"},{"key":"e_1_2_11_41_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2019.00406"},{"key":"e_1_2_11_42_1","doi-asserted-by":"publisher","DOI":"10.1086\/508206"},{"key":"e_1_2_11_43_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cis1000"},{"key":"e_1_2_11_44_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000000012"},{"key":"e_1_2_11_45_1","doi-asserted-by":"publisher","DOI":"10.9778\/cmajo.20140017"},{"key":"e_1_2_11_46_1","doi-asserted-by":"publisher","DOI":"10.1086\/648096"},{"key":"e_1_2_11_47_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.aids.0000299406.44775.de"},{"key":"e_1_2_11_48_1","doi-asserted-by":"publisher","DOI":"10.1097\/00126334-200405010-00011"},{"key":"e_1_2_11_49_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e31827f5c9a"}],"container-title":["Journal of the International AIDS Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jia2.25784","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/jia2.25784","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jia2.25784","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,28]],"date-time":"2023-08-28T09:56:37Z","timestamp":1693216597000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jia2.25784"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":48,"journal-issue":{"issue":"S5","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["10.1002\/jia2.25784"],"URL":"https:\/\/doi.org\/10.1002\/jia2.25784","archive":["Portico"],"relation":{},"ISSN":["1758-2652","1758-2652"],"issn-type":[{"value":"1758-2652","type":"print"},{"value":"1758-2652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"2021-03-26","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-07-19","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-09-21","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e25784"}}